ALPHAMIN ANNOUNCES SUCCESSFUL INFILL DRILLING AT MPAMA
Grand Baie, Mauritius Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX, “Alphamin”
Globe Newswire10-02-2023, 22:27
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26